Novel lipid-lowering therapies and cardiovascular risk management

被引：0
|
作者：
Rizzo, M. [1 ,2 ]
机构：
[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, Palermo, Italy
[2] Euromediterranean Inst Sci & Technol, Palermo, Italy
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
    Wilkins, John T.
    Lloyd-Jones, Donald M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (03): : 266 - 267
  • [2] Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk Reply
    Wilkins, John T.
    Lloyd-Jones, Donald M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (21): : 2205 - +
  • [3] Cardiovascular Pharmacogenetics of Antihypertensive and Lipid-Lowering Therapies
    Vanichakarn, P.
    Hwa, J.
    Stitham, J.
    [J]. CURRENT MOLECULAR MEDICINE, 2014, 14 (07) : 849 - 879
  • [4] New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
    Graham, Ian
    Shear, Chuck
    De Graeff, Pieter
    Boulton, Caroline
    Catapano, Alberico L.
    Stough, Wendy Gattis
    Carlsson, Stefan C.
    De Backer, Guy
    Emmerich, Joseph
    Greenfeder, Scott
    Kim, Albert M.
    Lautsch, Dominik
    Nguyen, Tu
    Nissen, Steven E.
    Prasad, Krishna
    Ray, Kausik K.
    Robinson, Jennifer G.
    Sasiela, William J.
    Slot, Karsten Bruins
    Stroes, Erik
    Thuren, Tom
    Van der Schueren, Bart
    Velkovski-Rouyer, Maja
    Wasserman, Scott M.
    Wiklund, Olov
    Zouridakis, Emmanouil
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) : 119 - 127
  • [5] Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk (vol 326, pg 266, 2021)
    Wilkins, J. T.
    Lloyd-Jones, D. M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (09): : 873 - 873
  • [6] New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins
    Luo, Fei
    Yu, Liqing
    Xian, Xunde
    Shan, Bo
    Das, Avash
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [7] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    [J]. DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [8] Lipid-lowering therapies in the management of acute coronary syndromes
    Mosca L.
    Biviano A.
    [J]. Current Cardiology Reports, 2002, 4 (4) : 320 - 326
  • [9] Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women
    Guetta, V
    Cannon, RO
    [J]. CIRCULATION, 1996, 93 (10) : 1928 - 1937
  • [10] Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events
    Lee, Sara
    Cannon, Christopher P.
    [J]. CURRENT CARDIOLOGY REPORTS, 2018, 20 (07)
12345